Migraine and cardiovascular disease;Migrânea e doenças cardiovasculares

Arquivos de Neuro-Psiquiatria

Volumn 69, Issue 1, 2011, Pages 122-129

  Bigal, Marcelo E ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Migraine; Stroke

Indexed keywords

ANGINA PECTORIS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CLAUDICATION; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; MIGRAINE; MIGRAINE WITH AURA; MORTALITY; PATHOPHYSIOLOGY; REVASCULARIZATION; REVIEW; RISK FACTOR;

EID: 79952341374     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2011000100023     Document Type: Review

References (56)

1. Task Force of the American Medical Association. Oral contraceptives and stroke in young women. Associated risk factors. JAMA 1975;231:718-722.
2. Elliott D. Migraine and stroke: current perspectives. Neurol Res 2008;30: 801-812.
3. Kurth T, Diener HC. Current views of the risk of stroke for migraine with and migraine without aura. Curr Pain Headache Rep 2006;10:214-220.
4. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
5. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005;64:1020-1026.
6. MacClellan LR, Mitchell BD, Cole JW, et al. Familial aggregation of ischemic stroke in young women: the Stroke Prevention in Young Women Study. Genet Epidemiol 2006;30:602-608.
7. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007;167:795-801.
8. Diener HC, Kuper M, Kurth T. Migraine-associated risks and comorbidity. J Neurol 2008;255:1290-1301.
9. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 2009;72:1864-1871.
10. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-657.
11. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-349.
12. Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olesen J. Classification of primary headaches. Neurology 2004;63:427-435.
13. Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;18(Suppl):S1-S156.
14. Classification Committee of the International Headache Society. The International Classification of Headache Disorders. 2nd Edition. Cephalalgia 2004;24(Suppl 1):S1-S149.
15. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006;5:148-157.
16. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med 2002;346:257-270.
17. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002;8:136-142.
18. Ophoff RA, Terwindt GM, Vergouwe MN, Frants RR, Ferrari MD. Familial hemiplegic migraine: involvement of a calcium neuronal channel. Neurologia 1997;12(Suppl 5):S31-S37.
19. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993;43(Suppl 3):S16-S20.
20. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56.
21. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001;357:1016-1017.
22. Goadsby P. What is the physiological role of the trigeminovascular system? Cephalalgia 1995;15:333.
23. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001;98:4687-4692.
24. Moskowitz MA, Kurth T. Blood vessels, migraine, and stroke. Stroke 2007;38: 3117-3118.
25. Porter A, Gladstone JP, Dodick DW. Migraine and white matter hyperintensities. Curr Pain Headache Rep 2005;9:289-293.
26. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006;37:1109-1112.
27. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330:63.
28. Buring JE, Hebert P, Romero J, et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 1995;52:129-134.
29. Diener HC, Kurth T. Is migraine a risk factor for stroke? Neurology 2005;64: 1496-1497.
30. Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005;64:1573-1577.
31. Charles A. Intercellular calcium waves in glia. Glia 1998;24:39-49.
32. Ayata C, Moskowitz MA. Cortical spreading depression confounds concentration- dependent pial arteriolar dilation during N-methyl-D-aspartate superfusion. Am J Physiol Heart Circ Physiol 2006;290:1837-1841.
33. Imamura K, Takeshima T, Fusayasu E, Nakashima K. Increased plasma matrix metalloproteinase-9 levels in migraineurs. Headache 2008;48:135-139.
34. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004;113:1447-1455.
35. Rosamond W. Are migraine and coronary heart disease associated? An epidemiologic review. Headache 2004;44 (Suppl 1):S5-S12.
36. Wayne VS. A possible relationship between migraine and coronary artery spasm. Aust N Z J Med 1986;16:708-710.
37. Rose KM, Carson AP, Sanford CP, et al. Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology 2004;63: 2233-2239.
38. Uyarel H, Erden I, Cam N. Acute migraine attack, angina-like chest pain with documented ST-segment elevation and slow coronary flow. Acta Cardiol 2005;60:221-223.
39. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-291.
40. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106:81-89.
41. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006;67:252-257.
42. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006;66:545-550.
43. Winter AC BK, Buring JE, Kurth T. Body mass index, migraine, migraine frequency, and migraine features in women. Cephalalgia in press.
44. Bigal ME, Lipton RB. Putative mechanisms of the relationship between obesity and migraine progression. Curr Pain Headache Rep 2008;12:207-212.
45. Haffner SM. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. Am J Med 2006;119 (Suppl 1):S3-S9.
46. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-620.
47. Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 2008;28:49-56.
48. Kunz GA, Liang G, Cuculi F, et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 2006;152:190-195.
49. Lee ST, Chu K, Jung KH, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008;70:1510-1517.
50. Scher AI, Terwindt GM, Verschuren WM, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006;59:372-375.
51. Schurks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 2008;71:505-513.
52. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339:3914.
53. Stewart WF RM, Bigal ME, Lipton RB. Lifetime migraine incidence. Results from the American Migraine Prevalence and Prevention study. Headache 2005;46:52-55.
54. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007;47:355-363.
55. D'Andrea G, Toldo M, Cananzi A, Ferro-Milone F. Study of platelet activation in migraine: control by low doses of aspirin. Stroke 1984;15:271-275.
56. Bigal ME, Kurth T, Santanello N, Buse D, et al. Migraine and cardiovascular disease: a population based study. Neurology 2010; 74:628-635.